BlackRock Americanome Trust (CHIX:BRAIL) Research & Development: £0.00 Mil (TTM As of Oct. 2025)


CHIX:BRAIL BlackRock American Income Trust Plc CHIX:BRAIL
32 GF Score
Price £2.01
! 6 Warning Signs
View Full Analysis

What is BlackRock Americanome Trust Research & Development?

BlackRock Americanome Trust CHIX:BRAIL 32 Research & Development is £0.00 Mil as of Oct. 2025. GuruFocus rates CHIX:BRAIL with a GF Score™ of 32/100. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BlackRock Americanome Trust's Research & Development for the six months ended in Oct. 2025 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2025 was £0.00 Mil.

BlackRock Americanome Trust  (CHIX:BRAIl) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BlackRock Americanome Trust Research & Development Related Terms

BlackRock Americanome Trust Research & Development Historical Data

* Premium members only.

The historical data trend for BlackRock Americanome Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BlackRock Americanome Trust Research & Development Chart

BlackRock Americanome Trust Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BlackRock Americanome Trust Semi-Annual Data
Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:BRAIL
32GF Score
BlackRock American Income Trust Plc CHIX:BRAIL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BlackRock Americanome Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.00 Mil mean?
BlackRock Americanome Trust (CHIX:BRAIL) has a Research & Development of £0.00 Mil as of Oct. 2025. Research and development expense is the total cost for research and development activities. View historical data on BlackRock Americanome Trust and its competitors.
Is BlackRock Americanome Trust's Research & Development too high?
BlackRock Americanome Trust's current Research & Development is £0.00 Mil. Overall, BlackRock Americanome Trust has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does BlackRock Americanome Trust's Research & Development compare to BLK and BX?
BlackRock Americanome Trust's Research & Development of £0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BlackRock Americanome Trust and its competitors. BlackRock Americanome Trust's current Research & Development is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BlackRock Americanome Trust stock overvalued right now?
BlackRock Americanome Trust (CHIX:BRAIL) has a current Research & Development of £0.00 Mil. The current Research & Development is £0.00 Mil. BlackRock Americanome Trust's overall GF Score™ is 32/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BlackRock Americanome Trust (CHIX:BRAIL), the current Research & Development is £0.00 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BlackRock Americanome Trust Business Description

Other Exchanges BRAI:UK
Address 12 Throgmorton Avenue, London, GBR, EC2N 2DL
BlackRock American Income Trust Plc is an investment trust company principally engaged in portfolio investment. The company's investment objective is to provide long-term capital growth, whilst paying an attractive level of income. The trust aims to achieve long-term capital growth and income by investing in a diversified portfolio of U.S. equity securities, with a focus on large-cap and mid-cap companies, using a systematic active investment approach.
32GF Score

Get the complete analysis for CHIX:BRAIL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.01
Price